crystal
| Price | USD0.10 |
| Packge | 1KG |
- Min. Order:1KG
- Supply Ability:1kg; 50kg; 500kg
- Time:2019-12-25
Product Details
- Product Name4-[2-(1-Pipiridine)ethoxybenzoic acid hydrochloride
- CAS No.84449-80-9
- EINECS No.282-882-9
- MFC14H20ClNO3
- MW285.77
- AppearanceSolidWhite
- Melting point 267-271°C dec.
- storage temp. Inert atmosphere,Room Temperature
▼
▲
4-[2-(1-Pipiridine)ethoxybenzoic acid hydrochloride Basic information
▼
▲
Product Name:
Synonyms:
Raloxifene Impurity 6;Benzoic acid,4-[2-(1-piperidinyl)ethoxy]-, hydrochloride (1:1);Raloxifene Benzoic Acid Impurity;4-[2-(1-piperridiyl)ethoxy] benzoic acid hydro chloride;4-(2-PIPERIDIN-1-YL-ETHOXY)-BENZOIC ACID HYDROCHLORIDE;4-(2-PIPERIDINOETHOXY)BENZOIC ACID HCL;4-[2-(1-PIPERIDINYL)ETHOXY]BENZOIC ACID HCL;4-[2-(1-PIPERIDINYL)ETHOXY]BENZOIC ACID HYDROCHLORIDE
CAS:
MF:
C14H20ClNO3
MW:
285.77
EINECS:
282-882-9
Product Categories:
Mol File:
▼
▲
4-[2-(1-Pipiridine)ethoxybenzoic acid hydrochloride Chemical Properties
▼
▲
Melting point
267-271°C dec.
storage temp.
Hygroscopic, -20°C Freezer, Under Inert Atmosphere
CAS DataBase Reference
▼
▲
Safety Information
▼
▲
▼
▲
4-[2-(1-Pipiridine)ethoxybenzoic acid hydrochloride Usage And Synthesis
▼
▲
Chemical Properties
White Solid
Uses
An intermediate in the synthesis of Raloxifene hydrochloride
Company Profile Introduction
Established in 2014,Career Henan Chemical Co. is a manufacturerspecializing in the sale of fine chemicals.
Mainly deals in the sales of:
Pharmaceutical intermediates
OLED intermediates：
Pharmaceutical intermediates;
OLED intermediates;
Recommended supplier
-
VIP1年
- SRINI PHARMACEUTICALS PVT LTD
- 84449-80-9 98%
- Inquiry
- 2025-05-09
- Gokul Eximp
- 4 Ethoxybenzoic Acid
- Inquiry
- 2025-09-23
-
VIP3年
- JSK Chemicals
- 619-86-3 4-Ethoxybenzoic acid, 99% 99%
- Inquiry
- 2025-03-05
-
VIP0年
- JSK Chemicals
- 619-86-3 4-Ethoxybenzoic acid, 99% 99%
- Inquiry
- 2025-03-05
- Since:2014-12-17
- Address: Room 702, Floor 7, Building 10, National University Science Park, High-Tech Zone, Zhengzhou City, H
INQUIRY